Today: 29 April 2026
S&P 500, Nasdaq futures climb as Venezuela takedown lifts Chevron and puts AI back in focus

S&P 500, Nasdaq futures climb as Venezuela takedown lifts Chevron and puts AI back in focus

New York, Jan 5, 2026, 09:21 (EST) — Premarket

  • S&P 500 and Nasdaq futures ticked higher ahead of the open, with energy shares leading gains after the U.S. captured Venezuela’s president.
  • Chevron and other oil names jumped on expectations U.S. firms could gain wider access to Venezuela’s vast reserves, even as an embargo remains in place.
  • Traders are watching ISM data later Monday, Friday’s U.S. jobs report, and CES tech headlines this week.

U.S. stock index futures rose on Monday, led by energy shares after the United States captured Venezuelan President Nicolás Maduro in a military operation that investors see as a potential turning point for access to the country’s oil. S&P 500 futures were up about 0.3% and Nasdaq futures gained roughly 0.7% in premarket trading.

The move matters because Venezuela sits on the world’s largest oil reserves, and any perceived shift in policy or control can ripple through crude markets, inflation expectations and, in turn, Federal Reserve rate bets. It also lands as Wall Street starts the first full trading week of 2026, with investors looking for steadier footing after last week’s losses.

Energy stocks outperformed even though the White House has said the U.S. embargo on Venezuelan oil exports remains in full effect for now. Traders are weighing whether the geopolitical jolt ultimately changes the flow of heavy crude into U.S. refineries — a key input for diesel and other fuels — or stays more of a longer-dated policy story.

President Donald Trump said a second strike was possible if remaining members of Venezuela’s administration do not cooperate, according to Reuters. Maduro is being held in New York and is due to appear in court on Monday, while the U.N. Security Council planned to meet to discuss the attack.

Chevron, the only U.S. major currently operating in Venezuela’s oil fields under a U.S. waiver, rose about 6.5% in premarket trading. Refiners Marathon Petroleum, Phillips 66, Valero and PBF Energy climbed between 4% and 11%, while oilfield-services firms such as Baker Hughes, Halliburton and SLB also advanced, as investors positioned for the possibility of renewed investment in Venezuela’s damaged oil infrastructure.

“It’s a geopolitical shock, but for markets it’s not an oil-price earthquake,” said Lale Akoner, global market analyst at eToro. Oil prices were mixed in early trading, with U.S. crude last down 36 cents at $56.96 a barrel and Brent down 34 cents at $60.41, AP reported. Reuters

Tech also helped buoy sentiment, with Nasdaq-linked contracts outperforming and chip names in focus on renewed artificial-intelligence optimism. Nvidia shares were up $2.59 at $191.44 in premarket trading, while Micron, Western Digital and SanDisk gained after reports pointed to potential memory shortages that could lift prices; Arista Networks rose after Piper Sandler upgraded the stock to “overweight” from “neutral,” Reuters said. Nasdaq

Investors are also bracing for a headline-heavy week around CES in Las Vegas, where companies are expected to lean hard into AI and autonomous-driving themes. Nvidia CEO Jensen Huang and AMD CEO Lisa Su are among the key speakers, Reuters reported, and Engadget said Huang’s keynote is scheduled for 4 p.m. ET on Monday.

On the macro front, traders will parse a run of U.S. labor-market releases for clues on how quickly the Fed might ease this year. Markets are pricing about 60 basis points — 0.60 percentage point — of rate cuts in 2026, according to LSEG data cited by Reuters, with the ISM manufacturing reading due after the opening bell and the monthly jobs report due Friday.

Still, the downside scenario is clear: any escalation in Venezuela — or a sudden shift in embargo policy — could reprice energy and inflation risk quickly, hitting rate-sensitive growth stocks that have driven much of the market’s upside. Safe-haven demand has already appeared in pockets, with gold and silver jumping as investors sought protection against geopolitical uncertainty, AP said.

Next up for markets is Monday’s ISM data, followed by Friday’s nonfarm payrolls report, while investors watch for updates from CES and developments around Maduro’s court appearance and the U.N. Security Council meeting later Monday.

Stock Market Today

  • CGI (TSX:GIB.A) Shares Seen 33% Undervalued Amid Mixed Performance
    April 29, 2026, 9:36 AM EDT. CGI's (TSX:GIB.A) stock has shown mixed returns recently, with a 1.94% gain over one month but a 14.05% decline over three months. Its current price around CA$100.64 is 33% below a fair value estimate of CA$149.62 from market analysts. This discount arises despite strong demand driven by digital transformation trends like cloud migration, AI automation, and data analytics. Investors face a balancing act between assessing CGI's growth potential and risks including client spending variability and integration challenges from acquisitions. The valuation gap highlights uncertainty whether the market undervalues this global IT services firm or preempts growth headwinds. Investors are advised to examine CGI's fundamentals and broader sector opportunities before committing capital.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
American Airlines stock in focus as Caribbean flights restart after FAA curbs lift
Previous Story

American Airlines stock in focus as Caribbean flights restart after FAA curbs lift

Oracle stock holds steady after Jefferies sticks with $400 target as Wall Street eyes jobs data
Next Story

Oracle stock holds steady after Jefferies sticks with $400 target as Wall Street eyes jobs data

Go toTop